查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1413094

发作性睡病治疗药物市场：按类型、治疗药物类型 - 全球预测 2024-2030

Narcolepsy Drugs Market by Type (Narcolepsy with Cataplexy, Narcolepsy without Cataplexy, Secondary Narcolepsy), Therapeutics Type (Central Nervous System Stimulants, Selective Serotonin Reuptake Inhibitor, Sodium Oxybate) - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年发作性睡病治疗药物市场规模为30.5亿美元，2024年预计将达32.8亿美元，2030年将达48.3亿美元，复合年增长率为6.77%。

发作性睡病药物的全球市场

主要市场统计
基准年[2023] 30.5亿美元
预测年份 [2024] 32.8亿美元
预测年份 [2030] 48.3亿美元
复合年增长率（%） 6.77%
发作性睡病治疗药物市场-IMG1

FPNV定位矩阵

FPNV定位矩阵对于评估发作性睡病药物市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出资讯的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对发作性睡病治疗药物市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵考察，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更资讯的决策并制定有效的策略，从而在市场上获得竞争优势。

该报告对以下几个方面提供了宝贵的见解：

1-市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2-市场开拓：我们深入研究利润丰厚的新兴市场，并分析它们在成熟细分市场中的渗透率。

3- 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4-竞争力评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5- 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1-发作性睡病治疗药物市场的市场规模和预测是多少？

2-在发作性睡病治疗药物市场的预测期内，有哪些产品、细分市场、应用和领域需要考虑投资？

3-发作性睡病药物市场的技术趋势和法律规范是什么？

4-发作性睡病治疗药物市场主要供应商的市场占有率是多少？

5-进入发作性睡病药物市场的合适型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 发作性睡病患病率增加
      • 提高消费者对发作性睡病药物益处的认识
      • 睡眠相关疾病的医疗费用增加
    • 抑制因素
      • 发作性睡病药物的副作用
    • 机会
      • 政府努力开发治疗发作性睡病的药物
      • 开发新药的持续研究和开发活动
    • 任务
      • 对新兴经济体的渗透率下降
  • 市场区隔分析
  • 市场趋势分析
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范

第六章发作性睡病治疗药物市场：依类型

  • 发作性睡病伴随猝倒
  • 不伴猝倒的发作性睡病
  • 次发性发作性睡病

第七章发作性睡病治疗药物市场（依治疗药物类型）

  • 中枢神经系统兴奋剂
  • 选择性血清素再回收抑制剂
  • 氧化钠
  • 三环抗忧郁药物

第八章美洲发作性睡病药物市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太地区发作性睡病治疗药物市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章 欧洲、中东和非洲的发作性睡病治疗市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争形势

  • FPNV定位矩阵
  • 市场占有率分析：按主要企业划分
  • 主要企业竞争情境分析

第12章竞争产品组合

  • 主要公司简介
    • Apotex Inc.
    • Aurobindo Pharma Ltd.
    • Avadel Pharmaceuticals Plc
    • Axsome Therapeutics Inc.
    • Cadila Pharmaceuticals Ltd.
    • Don Valley Pharmaceuticals
    • Graymark Healthcare Inc.
    • Jabs Biotech Pvt. Ltd.
    • Jazz Pharmaceuticals PLC
    • Luckys Pharma Pvt. Ltd.
    • Midas Pharma GmbH
    • Orbion Pharmaceuticals Pvt. Ltd.
    • Shionogi and Co. Ltd.
    • Takeda Pharmaceutical Co. Ltd.
    • Teva Pharmaceutical Industries Ltd.
    • XWPharma Ltd.
  • 主要产品系列

第十三章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-62667ADF9646

[195 Pages Report] The Narcolepsy Drugs Market size was estimated at USD 3.05 billion in 2023 and expected to reach USD 3.28 billion in 2024, at a CAGR 6.77% to reach USD 4.83 billion by 2030.

Global Narcolepsy Drugs Market

KEY MARKET STATISTICS
Base Year [2023] USD 3.05 billion
Estimated Year [2024] USD 3.28 billion
Forecast Year [2030] USD 4.83 billion
CAGR (%) 6.77%
Narcolepsy Drugs Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Narcolepsy Drugs Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Narcolepsy Drugs Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Narcolepsy Drugs Market, highlighting leading vendors and their innovative profiles. These include Apotex Inc., Aurobindo Pharma Ltd., Avadel Pharmaceuticals Plc, Axsome Therapeutics Inc., Cadila Pharmaceuticals Ltd., Don Valley Pharmaceuticals, Graymark Healthcare Inc., Jabs Biotech Pvt. Ltd., Jazz Pharmaceuticals PLC, Luckys Pharma Pvt. Ltd., Midas Pharma GmbH, Orbion Pharmaceuticals Pvt. Ltd., Shionogi and Co. Ltd., Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., and XWPharma Ltd..

Market Segmentation & Coverage

This research report categorizes the Narcolepsy Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Narcolepsy with Cataplexy
    • Narcolepsy without Cataplexy
    • Secondary Narcolepsy
  • Therapeutics Type
    • Central Nervous System Stimulants
    • Selective Serotonin Reuptake Inhibitor
    • Sodium Oxybate
    • Tricyclic Antidepressants
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Narcolepsy Drugs Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Narcolepsy Drugs Market?

3. What are the technology trends and regulatory frameworks in the Narcolepsy Drugs Market?

4. What is the market share of the leading vendors in the Narcolepsy Drugs Market?

5. Which modes and strategic moves are suitable for entering the Narcolepsy Drugs Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Narcolepsy Drugs Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of narcolepsy disorder
      • 5.1.1.2. Growing consumer awareness towards benefits of narcolepsy drugs
      • 5.1.1.3. Rising healthcare spending for sleep related disorders
    • 5.1.2. Restraints
      • 5.1.2.1. Side effects of narcolepsy drugs
    • 5.1.3. Opportunities
      • 5.1.3.1. Governmental initiatives for narcolepsy drug development
      • 5.1.3.2. Ongoing research and development activities for novel drug development
    • 5.1.4. Challenges
      • 5.1.4.1. Less penetration across developing economies
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Narcolepsy Drugs Market, by Type

  • 6.1. Introduction
  • 6.2. Narcolepsy with Cataplexy
  • 6.3. Narcolepsy without Cataplexy
  • 6.4. Secondary Narcolepsy

7. Narcolepsy Drugs Market, by Therapeutics Type

  • 7.1. Introduction
  • 7.2. Central Nervous System Stimulants
  • 7.3. Selective Serotonin Reuptake Inhibitor
  • 7.4. Sodium Oxybate
  • 7.5. Tricyclic Antidepressants

8. Americas Narcolepsy Drugs Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Narcolepsy Drugs Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Narcolepsy Drugs Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

  • 12.1. Key Company Profiles
    • 12.1.1. Apotex Inc.
    • 12.1.2. Aurobindo Pharma Ltd.
    • 12.1.3. Avadel Pharmaceuticals Plc
    • 12.1.4. Axsome Therapeutics Inc.
    • 12.1.5. Cadila Pharmaceuticals Ltd.
    • 12.1.6. Don Valley Pharmaceuticals
    • 12.1.7. Graymark Healthcare Inc.
    • 12.1.8. Jabs Biotech Pvt. Ltd.
    • 12.1.9. Jazz Pharmaceuticals PLC
    • 12.1.10. Luckys Pharma Pvt. Ltd.
    • 12.1.11. Midas Pharma GmbH
    • 12.1.12. Orbion Pharmaceuticals Pvt. Ltd.
    • 12.1.13. Shionogi and Co. Ltd.
    • 12.1.14. Takeda Pharmaceutical Co. Ltd.
    • 12.1.15. Teva Pharmaceutical Industries Ltd.
    • 12.1.16. XWPharma Ltd.
  • 12.2. Key Product Portfolio

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. NARCOLEPSY DRUGS MARKET RESEARCH PROCESS
  • FIGURE 2. NARCOLEPSY DRUGS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. NARCOLEPSY DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. NARCOLEPSY DRUGS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. NARCOLEPSY DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. NARCOLEPSY DRUGS MARKET DYNAMICS
  • FIGURE 7. NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2023 VS 2030 (%)
  • FIGURE 10. NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS NARCOLEPSY DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS NARCOLEPSY DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES NARCOLEPSY DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES NARCOLEPSY DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC NARCOLEPSY DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC NARCOLEPSY DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. NARCOLEPSY DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 20. NARCOLEPSY DRUGS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. NARCOLEPSY DRUGS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. NARCOLEPSY DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. NARCOLEPSY DRUGS MARKET SIZE, BY NARCOLEPSY WITH CATAPLEXY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. NARCOLEPSY DRUGS MARKET SIZE, BY NARCOLEPSY WITHOUT CATAPLEXY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. NARCOLEPSY DRUGS MARKET SIZE, BY SECONDARY NARCOLEPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 10. NARCOLEPSY DRUGS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM STIMULANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. NARCOLEPSY DRUGS MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. NARCOLEPSY DRUGS MARKET SIZE, BY SODIUM OXYBATE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. NARCOLEPSY DRUGS MARKET SIZE, BY TRICYCLIC ANTIDEPRESSANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS NARCOLEPSY DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES NARCOLEPSY DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC NARCOLEPSY DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. NARCOLEPSY DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 101. NARCOLEPSY DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 102. NARCOLEPSY DRUGS MARKET LICENSE & PRICING